The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...

Novo Nordisk says many Australians would be willing to pay the out-of-pocket costs for its blockbuster medicines, which can ...

Known as VENTURA, the multi-center program comprised placebo-controlled trials designed to evaluate aticaprant as an ...